Archives

Zendal and IAVI announce to partner to advance the tuberculosis vaccine candidate MTBVAC into efficacy trials. For more information, please read the Press Release

a vacancy for a Project Manager at European Vaccine Initiative (EVI). It will be a full time position in Germany. For more information, please read the Job vacancy at the EVI website

Institut Pasteur-Lille is organizing an international conference on BCG in November this year. More information, registration etc.  can be found here      

TBVI and IAVI have updated the TB Vaccine Development Pathway. This online tool provides a structured development path and gating criteria for TB vaccine candidates and may be useful for vaccine [...]

The  Virtual Global Forum on TB Vaccines took place from 20 – 22 April 2021, bringing together more than 365 researchers, product developers, policy makers, advocates, and other stakeholders from [...]

The FII Institute (Future Investment Initiative Institute) is a next generation global foundation working to ensure the world’s brightest ideas find their way to build, scale and create positive [...]

TBVI has coordinated the development of several new tools to support future TB vaccine clinical trials. Experts in the field together with researchers from the ongoing EDCTP-funded TB vaccine [...]

Vaccines protect people of all ages against disease. Immunization saves millions of lives every year and vaccines are widely recognized as one of the most successful health interventions. Yet, [...]

TBVI and EVI are building on a strong TB vaccine R&D community To discover and develop the next generation of TB vaccines it will be essential to build on the track record of European [...]

Developing a vaccine is a time-consuming and complex process, requiring a combination of specialized skills and technical capacities not readily available at a single organization. TRANSVAC2, [...]